3Itshayek E, Rosenthal G, Fraifeld S, et al. Delayed posttraumatic acute subdural hematoma in elderly patients on anticoagulation. Neurosurgery ,2006,58:851-856.
4Vacca V. Subdural hematoma. Nursing, 2006, 36:88.
5Coimbra R, Hoyt DB, Anjaria DJ,et al. Reversal of anticoagulation in trauma: a north american survey on clinical practices among trauma surgeons. J Trauma,2005,59:374-381.
6Reynolds FD, Dietz PA, Higgins D, et al. Time to deterioration of the elderly, anticoagulated, minor head injury patient who presents without evidence of neurologic abnormality. J Trauma, 2003, 54: 492-496.
7Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ, 2002,325:1073-1075.
8Tabrizi AR, Zehnbauer BA, Borecki IB, et al. The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients- receiving warfarin. J Am Coll Surg, 2002, 194: 267 -273.
9Ansell J, Hirsh J, Poller L, et al. The pharmacology management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 2004, 126: 204-233.
10Ageno W,Turpie AG,Steidl L,et al. Comparison of a daily fixed 2.5rag warfarin dose with a 5mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement. Am J Cardiol,2001,88 :40- 44.
4Jacobs L G.Warfarin pharmacology,clinical management,and evaluation of hemorrhagic risk for the elderly[J].Clin Geriatr Med,2006,22:17-32.
5Thomson BK,AacRae JM,Barnieh L,et al.Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients[J].BMC Nephrology,2011,12:46.
6Daniel E,Howard L.Genetic and clinical factors relating to warfarin dosing[J].Trends in Pharmacological Sciences,2009,30(7):375-386.
